Handling your D&O policy in an M&A Transaction
Merger and acquisition activity continues to hit record levels in almost all industries today.Â One important issue that needs to be addressed is what do you do with your D&O in an M&A transaction?
Yes, all your other policies need to be addressed as well, but during a transition point, the D&O policy has certain features that need to be addressed.
Directors and Officers Liability (D&O) like other management liability policies (Employment Practices, Fiduciary, etc.) have a provision that specifically addresses a merger, acquisition or sale of a business.Â The transaction clause in this policy effectively terminates coverage as of the transaction date.Â At that point, the policy is known to be “put into run-off.” This is a critical point to understand.
When the M&A transaction is signed, the selling party or the party (ies) willing to be merged into an existing or new entity, will have their D&O policy terminated.Â The premium for the policy in most cases is considered to be fully earned (meaning there is no refund for the â€śunusedâ€ť portion of the policy).Â Most importantly and the focus of this article is that the insured needs to make an election as to what to do with extending the policyâ€™s reporting period.
As a claims-made policy, there is a thorny issue to deal with at policy termination.Â What are you going to do with potential claims that may be presented after the policy terminates? Â If the insured does not elect to purchase an extended reporting period (commonly called a â€śtailâ€ť) than any future claims presented to the insured or their successor company for acts that occurred prior to the termination date will not be covered.
As a footnote, in some policies and amended by some states, there are short automatic extensions already built into the policy for 30, 60, or 90 days, which are very insufficient to protect the insured from long-tailed claim reportings.
As mentioned, this is a potential liability for the seller and for the buyer, so the purchase and sale agreement needs to address this issue and coverage extended appropriately.Â The common approach is to agree that the seller will purchase, at the transaction, an extended reporting period of at least three years (some deals push that out to 6 years).Â The cost of that extension can be 150% to 300% of the terminated policyâ€™s annual premium, depending on the duration of the tail and the insurer.Â Many D&O policies will contain what the charges are for the extended reporting period, but if youâ€™re unsure it is best to contact your broker.Â Who bears the cost of that extension?Â Often that will be wrapped into the deal terms with the buyer assuming the cost as part of the transaction.
While weâ€™ve talked about D&O in an M&A transaction, this same conversation applies to most all management and professional policies â€“ Employment Practice Liability, Fiduciary Liability, Errors & Omissions, Cyber, etc. are all forms written on claims made and should be addressed for run-off coverage.
For firms actively involved in buying and selling companies such as private equity, venture capital or investment banking the transaction clause or change in control provisions are well known, planned and thought out prior to a deal happening.Â Where we see this as problematic is when a privately held firm does one or two transactions during their lifecycle and the advisors to the transaction are not well informed to these particulars.Â Thatâ€™s why getting your insurance broker involved in discussions early on in negotiations can be important.Â If necessary, have non-disclosure agreements at the ready to protect the confidentiality of your deal terms, but getting professional guidance is critical to make sure youâ€™re not left with uninsured exposures following the close of your transaction.
For more information on how to handle your D&O policy during M&A, or other insurance issues that arise during the merger and acquisition process, please contact me for a conversation!